Literature DB >> 18581173

Clinical and morphologic correlation after stapled transanal rectal resection for obstructed defecation syndrome.

Daniel Dindo1, Dominik Weishaupt, Kuno Lehmann, Franc H Hetzer, Pierre-Alain Clavien, Dieter Hahnloser.   

Abstract

PURPOSE: The clinical and morphologic outcome of patients with obstructed defecation syndrome after stapled transanal rectal resection was prospectively evaluated.
METHODS: Twenty-four consecutive patients (22 women; median age, 61 (range, 36-74) years) who suffered from obstructed defecation syndrome and with rectal redundancy on magnetic resonance defecography were enrolled in the study. Constipation was assessed by using the Cleveland Constipation Score. Morphologic changes were determined by using closed-configuration magnetic resonance defecography before and after stapled transanal rectal resection.
RESULTS: After a median follow-up of 18 (range, 6-36) months, Cleveland Constipation Score significantly decreased from 11 (range, 1-23) preoperatively to 5 (range, 1-15) postoperatively (P = 0.02). In 15 of 20 patients, preexisting intussusception was no longer visible in the magnetic resonance defecography. Anterior rectoceles were significantly reduced in depth, from 30 mm to 23 mm (P = 0.01), whereas the number of detectable rectoceles did not significantly change. Complications occurred in 6 of the 24 patients; however, only two were severe (1 bleeding and 1 persisting pain requiring reintervention).
CONCLUSIONS: Clinical improvement of obstructed defecation syndrome after stapled transanal rectal resection correlates well with morphologic correction of the rectal redundancy, whereas correction of intussusception seems to be of particular importance in patients with obstructed defecation syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18581173     DOI: 10.1007/s10350-008-9412-3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

1.  Comparative outcome of stapled trans-anal rectal resection and macrogol in the treatment of defecation disorders.

Authors:  Ivano Biviano; Danilo Badiali; Laura Candeloro; Fortunée Irene Habib; Massimo Mongardini; Angelo Caviglia; Fiorella Anzini; Enrico S Corazziari
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Long-term results of stapled transanal rectal resection (STARR) for obstructive defecation syndrome.

Authors:  Andreas Ommer; Thomas M Rolfs; Martin K Walz
Journal:  Int J Colorectal Dis       Date:  2010-08-19       Impact factor: 2.571

Review 3.  [Transtar™ operation for rectocele and obstructed defecation syndrome].

Authors:  C Isbert
Journal:  Chirurg       Date:  2016-11       Impact factor: 0.955

Review 4.  [Transanal procedure for functional bowel diseases].

Authors:  C Isbert; C-T Germer
Journal:  Chirurg       Date:  2013-01       Impact factor: 0.955

5.  Short-term results after STARR versus internal Delorme for obstructed defecation: a non-randomized prospective study.

Authors:  N L Ohazuruike; J Martellucci; C Menconi; S Panicucci; G Toniolo; G Naldini
Journal:  Updates Surg       Date:  2014-01-16

6.  Clinical and functional evaluation of patients with rectocele and mucosal prolapse treated with transanal repair of rectocele and rectal mucosectomy with a single circular stapler (TRREMS).

Authors:  V M Leal; F S P Regadas; S M M Regadas; L R Veras
Journal:  Tech Coloproctol       Date:  2010-10-19       Impact factor: 3.781

7.  Rectocele and intussusception: is there any coherence in symptoms or additional pelvic floor disorders?

Authors:  R Hausammann; T Steffen; D Weishaupt; U Beutner; F H Hetzer
Journal:  Tech Coloproctol       Date:  2009-03-14       Impact factor: 3.781

8.  Postoperative MR Defecography following Failed STARR Procedure for Obstructive Defecation Syndrome: A Three-Centre Experience.

Authors:  Vittorio Piloni; Marco Possanzini; Mattia Bergamasco; Gianluca Santi
Journal:  Gastroenterol Res Pract       Date:  2017-10-03       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.